Concepedia

Adam Ivey

AI

Statistics

Publications

26

Citations

3.2K

H-Index

20

Active since

2012

Affiliations

King's College London(Current)

Monash University

The Royal Melbourne Hospital

The Alfred Hospital

Peter MacCallum Cancer Centre

Adam Ivey is an author at King's College London specializing in medicine, molecular oncology, and oncology.

Publications per year

2012–2024

26

Publications

26

Assessment of Minimal Residual Disease in Standard-Risk AML

Adam Ivey, Robert K. Hills, Michael A. Simpson et al. · New England Journal of Medicine · 2016 · 836 citations · Full text

, , +16

Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML

Courtney D. DiNardo, Ing Soo Tiong, Anna Quaglieri et al. · Blood · 2020 · 649 citations · Full text

, , +9

Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT): A Phase Ib Dose-Escalation Study of Venetoclax Combined With Modified Intensive Chemotherapy

Chong Chyn Chua, Andrew W. Roberts, John Reynolds et al. · Journal of Clinical Oncology · 2020 · 190 citations

, , +17

Combining BH3-mimetics to target both BCL-2 and MCL1 has potent activity in pre-clinical models of acute myeloid leukemia

Donia M. Moujalled, Giovanna Pomilio, Corina Ghiurau et al. · Leukemia · 2018 · 174 citations · Full text

, , +17

Molecular MRD status and outcome after transplantation in NPM1-mutated AML

Richard Dillon, Robert K. Hills, Sylvie Freeman et al. · Blood · 2020 · 166 citations · Full text

, , +3

1–5 of 26